Pharmacological Aspects of Corticosteroid Pulse Therapy
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 13 (sup54) , 6-9
- https://doi.org/10.3109/03009748409103852
Abstract
Pulse corticosteroid therapy involves intravenous administration of “suprapharmacological” doses (0.5–2 g) of prednisolone or its equivalents. This dose is usually given on three consecutive days and possibly once a month thereafter. The pharmacological effects of the single pulse dose lasted for about two days. Whether these effects differ quantitatively or qualitatively from the effects of the smaller, conventional doses is unclear at present. The usual side-effects of glucocorticoid therapy may occur with pulse therapy but evidently less frequently than with conventional modes of steroid therapy.Keywords
This publication has 10 references indexed in Scilit:
- Glucocorticosteroids I: Anti-inflammatory MechanismsHospital Practice, 1983
- Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndromeEuropean Journal of Clinical Pharmacology, 1982
- Realistic guidelines of corticosteroid therapy in rheumatic diseaseSeminars in Arthritis and Rheumatism, 1981
- Pharmacokinetics of intravenous and oral prednisolone.British Journal of Clinical Pharmacology, 1980
- SUPPRESSION OF THE IMMUNE RESPONSE BY STEROIDS1 Comparative Potency of Hydrocortisone,2 Methylprednisolone, and DexamethasoneTransplantation, 1980
- Dose-dependent pharmacokinetics of prednisone and prednisolone in manJournal of Pharmacy and Pharmacology, 1978
- Recovery of hypothalamic-pituitary-adrenal function after intermittent high-dose prednisolone and cytotoxic chemotherapyPostgraduate Medical Journal, 1977
- Rejection Crises in Human Renal Transplant RecipientsArchives of Surgery, 1972
- REVERSAL OF ACUTE CLINICAL AND EXPERIMENTAL ORGAN REJECTION USING LARGE DOSES OF INTRAVENOUS PREDNISOLONEThe Lancet, 1971
- Effects of a single large intravenous dose of methylprednisolone sodium succinateClinical Pharmacology & Therapeutics, 1970